WHITE PAPER
Read the White Paper
In a prior whitepaper entitled “The Top 10 Biden Healthcare Priority Focus Areas,” we highlighted the healthcare initiatives the Biden Administration has prioritized, as indicated by budgetary requests and proposed rule changes or investigations. In a historic move, President Joe Biden ended his presidential re-election campaign on July 21, 2024, only a few months before the election, and endorsed Vice President Kamala Harris. Subsequently, two weeks later, on August 5, 2024, Harris finally secured the Democratic presidential nomination, marking her as the first woman of color to lead a major party ticket.
With Vice President Kamala Harris now declared as the official Democratic presidential nominee, it becomes increasingly important for stakeholders across the healthcare spectrum to understand Harris’s healthcare priorities. This knowledge can help providers, life sciences companies, insurers, technology vendors, and investors to anticipate and prepare for potential continuity or changes in the healthcare landscape.
Douglas Hervey
Partner
Douglas Hervey is a partner at Cicero Group with an emphasis in healthcare and private equity services. Douglas most recently worked as a senior director for Leavitt Partners. As a senior director, Douglas enabled healthcare entities to more effectively aggregate data, automate research processes, and make sound growth-oriented strategic and investment decisions. He has worked on over 200 healthcare private equity investment deals, within 80 unique healthcare sub-segments, for over 40 investment funds.
Douglas earned his bachelor’s degree in international relations at Brigham Young University, after which he earned his juris doctorate from the University of Pittsburgh. Douglas also holds an MBA from Brigham Young University, where he was a Hawes Scholar.
Start a Conversation
Thank you for your interest in Cicero Group. Please select from the options below to get in touch with us.